Circulating markers to assess nutritional therapy in cystic fibrosis

Clinica Chimica Acta

Volumn 353, Issue 1-2, 2005, Pages 13-29

  Wood, Lisa G ^a   Gibson, Peter G ^a   Garg, Manohar L ^b  

^a JOHN HUNTER HOSPITAL   (Australia)

^b UNIVERSITY OF NEWCASTLE   (Australia)

Author keywords

Biomarkers; Cystic fibrosis; Inflammation; Nutritional management; Oxidative stress

Indexed keywords

ALPHA TOCOPHEROL; ANTIOXIDANT; ARACHIDONIC ACID; ASCORBIC ACID; BETA CAROTENE; BILE ACID; BIOLOGICAL MARKER; C REACTIVE PROTEIN; CYANOCOBALAMIN; ESSENTIAL FATTY ACID; IRON; LEUKOTRIENE B4; LINOLEIC ACID; MAGNESIUM; MINERAL; PANCREAS ENZYME; PROTEIN; RETINOL; SELENIUM; SODIUM; TRACE ELEMENT; VITAMIN D; VITAMIN K GROUP; ZINC;

AUTOSOMAL RECESSIVE DISORDER; BILE ACID METABOLISM; BRONCHIECTASIS; CALORIC INTAKE; CAUSE OF DEATH; CLINICAL FEATURE; CYSTIC FIBROSIS; DIET SUPPLEMENTATION; DIET THERAPY; ENERGY EXPENDITURE; ENZYME REPLACEMENT; FATTY LIVER; GASTROESOPHAGEAL REFLUX; GASTROINTESTINAL TRACT; HUMAN; INFERTILITY; INTESTINE OBSTRUCTION; LIPID DIET; LUNG FUNCTION; LUNG INFECTION; MALABSORPTION; MORBIDITY; MORTALITY; NUTRITIONAL SUPPORT; OXIDATIVE STRESS; PANCREAS INSUFFICIENCY; PRIORITY JOURNAL; PROTEIN MALNUTRITION; QUALITY OF LIFE; RECTUM PROLAPSE; RESPIRATORY FAILURE; RESPIRATORY SYSTEM; REVIEW; TREATMENT OUTCOME; VITAMIN SUPPLEMENTATION;

EID: 13544255753     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cccn.2004.11.002     Document Type: Review

References (149)

1. P.B. Pencharz, and P.R. Durie Nutritional management of cystic fibrosis Annu. Rev. Nutr. 13 1993 111 136
2. F.C. Collins Cystic fibrosis: molecular biology and therapeutic implications Science 256 1991 774 779
3. B.W. Ramsey, and T.F. Boat Outcome measures for clinical trials in cystic fibrosis. Summary of a cystic fibrosis foundation consensus conference J. Pediatr. 124 1994 177 192
4. B.W. Ramsey Management of pulmonary disease in patients with cystic fibrosis N. Engl. J. Med. 335 1996 179 188
5. S.C. FitzSimmons 1996 Annual data report 1997 Cystic Fibrosis Foundation Patient Registry Bethesda, Maryland, USA
6. R.K. Brown, H. Wyatt, J.F. Price, and F.J. Kelly Pulmonary dysfunction in cystic fibrosis is associated with oxidative stress Eur. Respir. J. 9 1996 334 339
7. T.F. Boat, M.J. Welsh, and A.L. Beaudet The metabolic basis of inherited disease 1989 McGraw-Hill New York
8. P. Birrer, G. McElvaney, A. Rudeberg, C. Wirz Sommer, S. Liechti-Gallati, and R. Kraemer Protease-antiprotease imbalance in the lungs of children with cystic fibrosis Am. J. Respir. Crit. Care Med. 150 1994 207 213
9. R. Buhl, A. Meyer, and C. Vogelmeier Oxidant-protease interaction in the lung. Prospects for antioxidant therapy Chest 110 1996 267S 272S
10. E.D. Allen Opportunities for the use of aerosolized alpha 1-antitrypsin for the treatment of cystic fibrosis Chest 110 1996 256S 260S
11. I.M. Balfour-Lynn, and R. Dinwiddie Role of corticosteroids in cystic fibrosis lung disease J. R. Soc. Med. 89 1996 8 13
12. S.M. Sawyer, C.F. Robertson, and G. Bowes Cystic fibrosis: a changing clinical perspective Aust. N.Z. J. Med. 27 1997 6 11
13. L. Hamer, and H.W. Parker Treatment of cystic fibrosis in adults Am. Fam. Physician 54 1996 1291 1297
14. D. Borowitz Pathophysiology of gastrointestinal complications of cystic fibrosis Semin. Respir. Crit. Care Med. 15 1994 391 401
15. J. Feigelson, F. Girault, and Y. Pecau Gastro-oesophageal reflux in patients with cystic fibrosis Acta Paediatr. Scand. 76 1987 989 990
16. J.C. Cunningham, and L.M. Taussig A guide to cystic fibrosis for parents and children 1989 Tucson Cystic Fibrosis Center, University of Arizona Health Sciences Centre Tucson, Arizona
17. P.B. Davis, M. Drumm, and M.W. Konstan State of the art: cystic fibrosis Am. J. Respir. Crit. Care Med. 154 1996 1229 1256
18. D.S. Borowitz, R.J. Grand, and P.R. Durie Use of pancreatic enzyme supplements for patients with cystic fibrosis in the context of fibrosing colonopathy Consensus Conf. Concepts Care: Cyst. Fibros. Found. 6 1995 116 121
19. A. Moran Diabetes and glucose intolerance in cystic fibrosis New Insights Cyst. Fibros. 5 1997 1 6
20. S. FitzSimmons The changing epidemiology of cystic fibrosis J. Pediatr. 122 1993 1 9
21. D. Gurwitz, M. Corey, P.W.J. Francis, D. Crozier, and H. Levison Perspectives in cystic fibrosis Pediatr. Clin. North Am. 26 1979 603 615
22. E. Luder, M. Kattan, J.C. Thornton, K.M. Koehler, and R.J. Bonforte Efficacy of a non-restricted fat diet in patients with cystic fibrosis Am. J. Dis. Child 143 1989 458 464
23. R.W. Shepherd, T.L. Holt, B.J. Thomas, L. Kay, A. Isles, and P.J. Francis Nutritional rehabilitation in cystic fibrosis: controlled studies of effects on nutritional growth retardation, body protein turnover and course of pulmonary disease J. Pediatr. 109 1986 788 794
24. A. Sproul, and N. Huang Growth patterns in children with cystic fibrosis J. Pediatr. 118 1991 865 872
25. J.A. Dodge, and A.M. O'Rawe Nutritional aspects in cystic fibrosis Eur. J. Gastroenterol. Hepatol. 8 1996 739 743
26. J.E. Grunow, M.P. Azcue, G. Berrall, and P.B. Pencharz Energy expenditure in cystic fibrosis during activity of daily living J. Pediatr. 122 1993 243 246
27. N. Vaisman, P.B. Pencharz, M. Corey, G.J. Canny, and E. Hahn Energy expenditure of patients with cystic fibrosis J. Pediatr. 111 1987 496 500
28. L. Burdet, O. Hugli, J.D. Aubert, Y. Schutz, M. Roulet, and J.W. Fitting Effect of elective antibiotic therapy on resting energy expenditure and inflammation in cystic fibrosis Eur. J. Pediatr. 158 1999 711 716
29. G. Steinkamp, A. Drommer, and H. von der Hardt Resting energy expenditure before and after treatment for Pseudomonas aeruginosa infection in patients with cystic fibrosis Am. J. Clin. Nutr. 57 1993 685 689
30. S.C. Bell, M.J. Saunders, J.S. Elborn, and D.J. Shale Resting energy expenditure and oxygen cost of breathing in patients with cystic fibrosis Thorax 51 1996 126 131
31. N. Vaisman, L.D. Levy, P.B. Pencharz, Y.K. Tan, S.J. Soldin, and G.J. Canny Effect of salbutamol on resting energy expenditure in patients with cystic fibrosis J. Pediatr. 111 1987 137 139
32. L.G. Wood, D.A. Fitzgerald, P.G. Gibson, D.M. Cooper, and M.L. Garg Increased plasma fatty acid concentration following respiratory exacerbations in cystic fibrosis is associated with elevated oxidative stress Am. J. Clin. Nutr. 75 2002 668 675
33. P. Vic, S. Ategbo, F. Gottrand, V. Launay, G.A. Loeuille, and J.C. Elian Nutritional impact of antipseudomonas intravenous antibiotic courses in cystic fibrosis Arch. Dis. Child. 76 1997 437 440
34. M. Corey, F.J. McLaughlin, M. Williams, and H. Levison A comparison of survival growth and pulmonary function in patients with CF J. Clin. Epidemiol. 41 1988 583 591
35. J.A. Dodge Nutritional requirements in cystic fibrosis: a review J. Pediatr. Gastroenterol. 7 1988 58
36. A. MacDonald Nutritional management of cystic fibrosis Arch. Dis. Child. 74 1996 81 87
37. B.W. Ramsey, P.M. Farrell, and P. Pencharz Nutritional assessment and management in cystic fibrosis: a consensus report. The Consensus Committee Am. J. Clin. Nutr. 55 1992 108 116
38. D.N. Homnick, J.H. Cox, M.J. DeLoof, and T.V. Ringer Carotenoid levels in normal children and in children with cystic fibrosis J. Pediatr. 122 1993 703 707
39. H. Benabdeslam, I. Garcia, G. Bellon, R. Gilly, and A. Revol Biochemical assessment of the nutritional status of cystic fibrosis patients treated with pancreatic enzyme extracts Am. J. Clin. Nutr. 67 1998 912 918
40. H. Benabdeslam, H. Abidi, I. Garcia, G. Bellon, R. Gilly, and A. Revol Lipid peroxidation and antioxidant defences in cystic fibrosis Clin. Chem. Lab. Med. 37 1999 511 516
41. M. Rasmussen, H. Michalsen, S.O. Lie, A. Nilsson, L.B. Petersen, and K.R. Norum Intestinal retinol esterification and serum retinol in children with cystic fibrosis J. Pediatr. Gastroenterol. Nutr. 5 1986 397 403
42. D.R. James, G. Owen, I.A. Campbell, and M.C. Goodchild Vitamin A absorption in cystic fibrosis: risk of hypervitaminosis A Gut 33 1992 707 710
43. L.G. Wood, D.A. Fitzgerald, P.G. Gibson, D.M. Cooper, C.E. Collins, and M.L. Garg Oxidative stress in cystic fibrosis: dietary and metabolic factors J. Am. Coll. Nutr. 20 2001 157 165
44. R.J. Rayner, J.C. Tyrrell, E.J. Hiller, C. Marenah, M.A. Neugebauer, and S.A. Vernon Night blindness and conjunctival xerosis caused by vitamin A deficiency in patients with cystic fibrosis Arch. Dis. Child. 64 1989 1151 1156
45. T.R. Frieden, A.C. Sowell, K.J. Henning, D.L. Huft, and R.A. Gunn Vitamin A levels and severity of measles: New York city Am. J. Dis. Child 146 1992 182 186
46. K.M. Neuzil, W.C. Gruber, F. Chytil, M.T. Stahlman, B. Engelhardt, and B.S. Graham Serum vitamin A levels in respiratory syncytial virus infection J. Pediatr. 124 1994 433 436
47. C. Duggan, A.A. Collin, A. Agil, L. Higgins, and N. Rifai Vitamin A status in acute exacerbations of cystic fibrosis Am. J. Clin. Nut. 64 1996 635 639
48. VERIS Carotenoids fact book 1996 Veris Research Information Service LaGrange, Illinois, USA
49. B.M. Winklhofer-Roob, D.H. Schmerling, and M.G. Schimek High prevalence of very low beta-carotene in patients with cystic fibrosis (abstr) J. Vitam. Nutr. Res. 61 1991 271
50. B.M. Winklhofer-Roob Oxygen free radicals and antioxidants in cystic fibrosis: the concept of an oxidant-antioxidant imbalance Acta Paediatr. 83 1994 49 57 (Supplement)
51. B.M. Winklhofer-Roob, M.A. van't Hof, and D.H. Shmerling Response to oral beta-carotene supplementation in patients with cystic fibrosis: a 16-month follow-up study Acta Paediatr. 84 1995 1132 1136
52. B.M. Winklhofer-Roob, H.P. Puhl, G. Khoschsorur, M.A. van't Hof, H. Esterbauer, and D.H. Schmerling Enhanced resistance to oxidation of low density lipoproteins and decreased lipid peroxide formation during beta-carotene supplementation in cystic fibrosis Free Radic. Biol. Med. 18 1995 849 859
53. B.M. Winklhofer-Roob, O. Ziouzenkova, H. Puhl, H. Ellemunter, P. Greiner, and G. Muller Impaired resistance to oxidation of low density lipoprotein in cystic fibrosis: improvement during vitamin E supplementation Free Radic. Biol. Med. 19 1995 725 733
54. B.M. Winklhofer-Roob, S.E. Schlegel-Haueter, G. Khoschsorur, M.A. van't Hof, S. Suter, and D.H. Schmerling Neutrophil elastase/alpha 1-proteinase inhibitor complex levels decrease in plasma of cystic fibrosis patients during long-term oral beta-carotene supplementation Pediatr. Res. 40 1996 130 134
55. B.C. Portal, M.-J. Richard, H.S. Faure, A.J. Hadjian, and A.E. Favier Altered antioxidant status and increased lipid peroxidation in children with cystic fibrosis Am. J. Clin. Nutr. 61 1995 843 847
56. P. Rust, I. Eichler, S. Renner, and I. Elmadfa Effects of long term oral beta-carotene supplementation on lipid peroxidation in patients with cystic fibrosis Int. J. Vitaminol. Nutr. Res. 68 1998 83 87
57. G. Lepage, J. Champagne, N. Ronco, A. Lamarre, I. Osberg, and R.J. Sokol Supplementation with carotenoids corrects increased lipid peroxidation in children with cystic fibrosis Am. J. Clin. Nutr. 64 1996 87 93
58. E.I. Back, C. Frindt, D. Nohr, J. Frank, R. Ziebach, and M. Stern Antioxidant deficiency in cystic fibrosis: when is the right time to take action? Am. J. Clin. Nutr. 80 2004 374 384
59. P. Palozza, and N.I. Krinsky The inhibition of radical-initiated peroxidation of microsomal lipids by both α-tocopherol and β-carotene Free Radic. Biol. Med. 11 1991 407 414
60. H.J. Willison, D.P.R. Muller, S. Matthews, S. Jones, A. Kriss, and R.J. Stead A study of the relationship between neurological function and serum vitamin E concentrations in patients with cystic fibrosis J. Neurol. Neurosurg. Psychiatry 48 1985 1097 1102
61. B. Winklhofer-Roob, D.H. Shmerling, M.G. Schimek, and P. Tuchschmid Significance of dl-alpha-tocopherol acetate supplementation in patients with cystic fibrosis (abstr.) Pediatr. Res. 28 1990 283
62. B.M. Winklhofer-Roob, M.A. van't Hof, and D.H. Schmerling Long-term oral vitamin E supplementation in cystic fibrosis patients: RRR-alpha-tocopherol compared with all-rac-alpha-tocopheryl acetate preparations Am. J. Clin. Nutr. 63 1996 722 728
63. B. Biggemann, M.D. Laryea, A. Schuster, M. Griese, D. Reinhardt, and H.J. Bremer Status of plasma and erythrocyte fatty acids and vitamin A and E in young children with cystic fibrosis Scand. J. Gastroenterol. 23 1988 134 141
64. P.J. Congden, G. Bruce, and M.M. Rothburn Vitamin status in treated patients with cystic fibrosis Arch. Dis. Child. 56 1981 708 714
65. P.M. Farrell, J.G. Bieri, J.F. Fratantoni, R.E. Wood, and P.A. Di Sant'Agnese The occurrence and effects of human vitamin E deficiency. A study of patients with cystic fibrosis J. Clin. Invest. 60 1977 233 241
66. C. Dominguez, S. Gartner, S. Linan, N. Cobos, and A. Moreno Enhanced oxidative damage in cystic fibrosis patients BioFactors 8 1998 149 153
67. A. Martin The use of antioxidants in healing Dermatol. Surg. 22 1996 156 160
68. B.S. Wilfond, P.M. Farrell, A. Laxova, and E. Mischler Severe hemolytic anemia associated with vitamin E deficiency in infants with cystic fibrosis Clin. Pediatr. 33 1994 2 7
69. E.O. Reiter, S.M. Brugman, J.W. Pike, M. Pitt, S. Dokoh, and M.R. Haussler Vitamin D metabolites in adolescents and young adults with cystic fibrosis: effects of sun and season J. Pediatr. 106 1985 21 26
70. G.N. Thompson Determinants of serum vitamin D levels in preadolescent cystic fibrosis children Acta Paediatr. Scand. 76 1987 962 965
71. L.T. Beker, R.A. Ahrens, R.J. Fink, O.B. ME, K.W. Davidson, and L.J. Sokoll Effect of vitamin K1 supplementation on vitamin K status in cystic fibrosis patients J. Pediatr. Gastroenterol. Nutr. 24 1997 512 517
72. I.A. Choonara, M.J. Winn, B.K. Park, and J.M. Littlewood Plasma vitamin K1 concentrations in cystic fibrosis Arch. Dis. Child. 64 1989 732 734
73. A. Christophe, and E. Robberecht Current Knowledge on fatty acids in cystic fibrosis Prostaglandins Leukot. Essent. Fat. Acids 55 1996 129 138
74. P.M. Farrell, E.H. Mischler, M.J. Engle, D.J. Brown, and S.-M. Lau Fatty acid abnormalities in cystic fibrosis Pediatr. Res. 19 1985 104 109
75. R.A. Gibson, J.K. Teubner, K. Haines, D.M. Cooper, and G.P. Davidson Relationship between pulmonary function and plasma fatty acid levels in cystic fibrosis patients J. Pediatr. Gastroenterol. Nutr. 5 1986 408 415
76. M. Roulet, P. Frascarolo, I. Rappaz, and M. Pilet Essential fatty acid deficiency in well nourished young cystic fibrosis patients Eur. J. Pediatr. 156 1997 952 956
77. E. Levy, G. Lepage, and M. Bendayan Relationship of decreased hepatic lipase activity and lipoprotein abnormalities to essential fatty acid deficiency in cystic fibrosis patients J. Lipid Res. 30 1989 1197 1209
78. H.G. Parsons, E.V. O'Loughlin, D. Forbes, D. Cooper, and G. Gall Supplemental calories improve essential fatty acid deficiency in cystic fibrosis patients Pediatr. Res. 24 1988 353 356
79. F.N. Bhura-Bandali, M. Suh, S.F.P. Man, and M.T. Clandinin The deltaF508 mutation in the cystic fibrosis transmembrane conductance regulator alters control of essential fatty acid utilisation in epithelial cells J. Nutr. 130 2000 2870 2875
80. J. Bezard, J.P. Blond, A. Bernard, and P. Clouet The metabolism and availability of essential fatty acids in animal and human tissues Reprod. Nutr. Dev. 34 1994 539 568
81. B. Strandvik, E. Gronowitz, F. Enlund, T. Martinsson, and J. Wahlstrom Essential fatty acid deficiency in relation to genotype in patients with cystic fibrosis J. Pediatr. 138 2001 650 655
82. A.W. van Egmond, M.R. Kosorok, R. Koscik, A. Laxova, and P.M. Farrell Effect of linoleic acid intake on growth of infants with cystic fibrosis Am. J. Clin. Nutr. 63 1996 746 752
83. M.C. Craig-Schmidt, S.A. Faircloth, P.A. Teer, J.D. Weete, and C.-Y. Wu The essential fatty acid deficient chicken as a model for cystic fibrosis Am. J. Clin. Nutr. 44 1986 816 824
84. T.B. Harper, H.P. Chase, J. Henson, and P.M. Henson Essential fatty acid deficiency in the rabbit as a model of nutritional impairment in cystic fibrosis: in vitro and in vivo effects on lung defense mechanisms Am. Rev. Respir. Dis. 126 1982 540 547
85. J.A. Dodge The aetiology of fibrosing colonopathy Postgrad. Med. J. 72 1996 S52 S55
86. J.D. Lloyd-Still, and H.E. Ganther Selenium and glutathione peroxidase levels in cystic fibrosis Pediatrics 65 1980 1010 1012
87. R.J. Stead, A.N. Redington, and L.J. Hinks Selenium deficiency and possible increased risk of carcinoma in adults with cystic fibrosis Lancet 2 1985 862 863
88. J. Neve, R. van Geffel, M. Hanocq, and L. Molle Plasma and erythrocyte zinc, copper and selenium in cystic fibrosis Acta Paediatr. Scand. 72 1983 437 440
89. R. Castillo, C. Landon, and K. Eckhardt Selenium and vitamin E status in cystic fibrosis J. Pediatr. 99 1981 583 585
90. T. Laskowska-Klita, and M. Chelchowska Antioxidant status in erythrocytes of cystic fibrosis children Acta Biochim. Pol. 48 2001 283 285
91. B.M. Winkhofer-Roob, D.H. Schmerling, and P.E. Tuchschmid Parameters of the antioxidant protective system in patients with cystic fibrosis (abstr.) Pediatr. Res. 27 1990 533
92. N.W. Solomons, J.B. Wagonfeld, C. Rieger, R.A. Jacob, and M. Bolt Some biochemical indices of nutrition in treated cystic fibrosis patients Am. J. Clin. Nutr. 34 1981 462 474
93. C.G. Taylor, W.J. Bettger, and T.M. Bray The effect of dietary zinc or copper deficiency on the primary free radical defense system in rats J. Nutr. 118 1988 613 621
94. W.J. Bettger Zinc and selenium, site-specific versus general antioxidation Can. J. Physiol. Pharm. 71 1993 721 724
95. B. Matkovics, Gyurkovits, A. Laszlo, and L. Szabo Altered peroxide metabolism in erythrocytes from children with cystic fibrosis Clin. Chim. Acta 125 1982 59 62
96. S. Shull, N.H. Heintz, M. Periasamy, M. Manohar, Y.M.N. Janssen, and J.P. Marsh Differential regulation of antioxidant enzymes in response to oxidants J. Biol. Chem. 266 1991 24398 24403
97. T.M. Bray, and W.J. Bettger The physiological role of zinc as an antioxidant Free Radic. Biol. Med. 8 1990 281 291
98. B.M. Winklhofer-Roob, H. Ellemunter, M. Fruhwirth, S.E. Schlegel-Haueter, G. Khoschsorur, and M.A. van't Hof Plasma vitamin C concentrations in patients with cystic fibrosis: evidence of associations with lung inflammation Am. J. Clin. Nutr. 65 1997 1858 1866
99. S.H. Abman, F.J. Accurso, and C.M. Bowman Persistent morbidity and mortality of protein calorie malnutrition in young infants with cystic fibrosis J. Pediatr. Gastroenterol. Nutr. 5 1986 393 396
100. R.J. Sokol, M.C. Reardon, F.J. Accurso, C. Stall, M. Narkewicz, and S.H. Abman Fat-soluble-vitamin status during the first year of life in infants with cystic fibrosis identified by screening of newborns Am. J. Clin. Nutr. 50 1989 1064 1071
101. K.J. Davies Oxidative stress: the paradox of aerobic life Biochem. Soc. Symp. 61 1995 1 31
102. P. Linsdell, and J.W. Hanrahan Glutathione permeability of CFTR Am. J. Physiol. 275 1998 C323 C326
103. M.W. Konstan, and M. Berger Infection and inflammation of the lung in cystic fibrosis 1993 Marcel Dekker New York
104. D.S. Holsclaw Cystic fibrosis and pulmonary involvement from multiple perspectives Semin. Respir. Infect. 7 1993 141 150
105. R.G. Crystal Oxidants and respiratory tract epithelial injury: pathogenesis and strategies for therapeutic intervention Am. J. Med. 91 1991 39S 44S
106. R.K. Brown, and F.J. Kelly Role of free radicals in the pathogenesis of cystic fibrosis Thorax 49 1994 738 742
107. C.E. Collins, P. Quaggiotto, L. Wood, E.V. O'Loughlin, R.L. Henry, and M.L. Garg Elevated plasma levels of F2alpha isoprostane in cystic fibrosis Lipids 34 1999 551 556
108. G. Ciabattoni, G. Davi, M. Collura, L. Japichino, F. Pardo, and A. Ganci In vivo lipid peroxidation and platelet activation in cystic fibrosis Am. J. Respir. Crit. Care Med. 162 2000 1195 1201
109. R.K. Brown, and F.J. Kelly Evidence for increased oxidative damage in patients with cystic fibrosis Pediatr. Res. 36 1994 487 493
110. J.H. Widdicombe Accumulation of airway mucus in cystic fibrosis Pulm. Pharmacol. 7 1994 225 233
111. R.K. Brown, A. McBurney, J. Lunec, and F.J. Kelly Oxidative damage to DNA in patients with cystic fibrosis Free Radic. Biol. Med. 18 1995 801 806
112. C.M.F. Kneepkens, C. Ferreira, G. Lepage, and C.C. Roy Hydrocarbon breath test in cystic fibrosis: evidence for increased lipid peroxidation (abstr.) J. Pediatr. Gastroenterol. Nutr. 15 1992 344
113. P. Paredi, S.A. Kharitonov, D. Leak, P.L. Shah, D. Cramer, and M.E. Hodson Exhaled ethane is elevated in cystic fibrosis and correlates with carbon monoxide levels and airway obstruction Am. J. Resp. Crit. Care Med. 161 2000 1247 1251
114. P. Paredi, P.L. Shah, P. Montuschi, P. Sullivan, M.E. Hodson, and S.A. Kharitonov Increased carbon monoxide in exhaled air of patients with cystic fibrosis Thorax 54 1999 917 920
115. P. Montuschi, S.A. Kharitonov, G. Ciabattoni, M. Corradi, L. Van Rensen, and D.M. Geddes Exhaled 8-isoprostane as a new non-invasive biomarker of oxidative stress in cystic fibrosis Thorax 55 2000 205 209
116. B. Balint, S.A. Kharitonov, T. Hanazawa, L.E. Donnelly, P.L. Shah, and M.E. Hodson Increased nitrotyrosine in exhaled breath condensate in cystic fibrosis Eur. Respir. J. 17 2001 1201 1207
117. S. Renner, R. Rath, P. Rust, S. Lehr, T. Frischer, and I. Elmadfa Effects of beta-carotene supplementation for six months on clinical and laboratory parameters in patients with cystic fibrosis Thorax 56 2001 48 52
118. L.G. Wood, D.A. Fitzgerald, A.K. Lee, and M.L. Garg Improved antioxidant and fatty acid status following antioxidant supplementation is linked to improved lung function in cystic fibrosis Am. J. Clin. Nutr. 77 2003 150 159
119. T.P. Dean, Y. Dai, J.K. Shute, M.K. Church, and J.O. Warner Interleukin-8 concentrations are elevated in bronchoalveolar lavage, sputum, and sera of children with cystic fibrosis Pediatr. Res. 34 1993 159 161
120. H.A. Wyatt, A.P. Sampson, I.M. Balfour-Lynn, and J.F. Price Production of the potent neutrophil chemokine, growth-related protein alpha (GROalpha), is not elevated in cystic fibrosis children Respir. Med. 94 2000 106 111
121. S. Suter, U.B. Schaad, P. Roux-Lombard, E. Girardin, G. Grau, and J.M. Dayer Relation between tumor necrosis factor-alpha and granulocyte elastase-alpha 1-proteinase inhibitor complexes in the plasma of patients with cystic fibrosis Am. Rev. Respir. Dis. 140 1989 1640 1644
122. L.S. Nixon, B. Yung, S.C. Bell, S. Elborn, and D.J. Shale Circulating immunoreactive interleukin-6 in cystic fibrosis Am. J. Respir. Crit. Care Med. 157 1998 1764 1769
123. J.S. Elborn, S.M. Cordon, P.J. Western, I.A. Macdonald, and D.J. Shale Tumour necrosis factor-alpha, resting energy expenditure and cachexia in cystic fibrosis Clin. Sci. 85 1993 563 568
124. E. Levy, C. Gurbindo, F. Lacaille, K. Paradis, L. Thibault, and E. Seidman Circulating tumor necrosis factor-alpha levels and lipid abnormalities in patients with cystic fibrosis Pediatr. Res. 34 1993 162 166
125. D. Norman, J.S. Elborn, S.M. Cordon, R.J. Rayner, M.S. Wiseman, and E.J. Hiller Plasma tumour necrosis factor alpha in cystic fibrosis Thorax 46 1991 91 95
126. L.E. Kurlandsky, M.R. Bennink, P.M. Webb, P.J. Ulrich, and L.J. Baer The absorption and effect of dietary supplementation with omega-3 fatty acids on serum leukotriene B4 in patients with cystic fibrosis Pediatr. Pulmonol. 18 1994 211 217
127. R.J. Rayner, M.S. Wiseman, S.M. Cordon, D. Norman, E.J. Hiller, and D.J. Shale Inflammatory markers in cystic fibrosis Respir. Med. 85 1991 139 145
128. B. Niggemann, T. Stiller, K. Magdorf, and U. Wahn Myeloperoxidase and eosinophil cationic protein in serum and sputum during antibiotic treatment in cystic fibrosis patients with Pseudomonas aeruginosa infection Mediat. Inflamm. 4 1995 282 288
129. D.Y. Koller, M. Gotz, C. Wojnarowski, and I. Eichler Relationship between disease severity and inflammatory markers in cystic fibrosis Arch. Dis. Child. 75 1996 498 501
130. E. Osika, J.M. Cavaillon, K. Chadelat, M. Boule, C. Fitting, and G. Tournier Distinct sputum cytokine profiles in cystic fibrosis and other chronic inflammatory airway disease Eur. Resp. J. 14 1999 339 346
131. G.E. Carpagnano, P.J. Barnes, D.M. Geddes, M.E. Hodson, and S.A. Kharitonov Increased leukotriene B4 and interleukin-6 in exhaled breath condensate in cystic fibrosis Am. J. Respir. Crit. Care Med. 167 2003 1109 1112
132. T.L. Bonfield, J.R. Panuska, M.W. Konstan, K.A. Hilliard, J.B. Hilliard, and H. Ghnaim Inflammatory cytokines in cystic fibrosis lungs Am. J. Respir. Crit. Care Med. 152 1995 2111 2118
133. J.D. Lloyd-Still, S.B. Johnson, and R.T. Holman Essential fatty acid status in cystic fibrosis and the effects of safflower oil supplementation Am. J. Clin. Nutr. 34 1981 1 7
134. H.P. Chase, and J. Dupont Abnormal levels of prostaglandins and fatty acids in blood of children with cystic fibrosis Lancet 1978 236 238
135. E.H. Mischler, S.W. Parrell, P.M. Farrell, W.J. Raynor, and R.J. Lemen Correction of linoleic acid deficiency in cystic fibrosis Pediatr. Res. 20 1986 36 41
136. M.L. Garg, E. Sebokova, A.B.R. Thomson, and M.T. Clandinin Delta-6 desaturase activity in liver microsomes of rats fed diets enriched with cholesterol and/or fatty acids Biochem. J. 249 1988 351 356
137. R. Gorlin The biological actions and potential clinical significance of dietary omega 3 fatty acids Arch. Intern. Med. 148 1988 2043 2048
138. S. Endres, R. Ghorbani, and V.E. Kelly The effect of dietary supplementation with n-3 polyunsaturated fatty acids on the synthesis of interleukin-1 and tumor necrosis factor by mononuclear cells N. Engl. J. Med. 320 1989 265 271
139. R. Lawrence, and T. Sorrell Eicosapentaenoic acid in cystic fibrosis: evidence of a pathogenetic role for leukotriene B4 Lancet 342 1993 465 469
140. G. Lepage, D.W. Yesair, N. Ronco, J. Champagne, N. Bureau, and S. Chemtob Effect of an organised lipid matrix on absorption and clinical outcomes in patients with cystic fibrosis J. Pediatr. 141 2002 178 185
141. N. Beckles Willson, T.M. Elliott, and M.L. Everard Omega-3 fatty acids (from fish oils) for cystic fibrosis Cochrane Database Syst. Rev. 3 2002 CD002201
142. S.L. Archer Fish oil as a therapy for lung disease Nutrition 12 1996 372 374
143. J.V. Higdon, J. Liu, S.H. Du, J.D. Morrow, B.N. Ames, and R.C. Wander Supplementation of postmenopausal women with fish oil rich in eicosapentaenoic acid is not associated with greater in vivo lipid peroxidation compared with oils rich in oleate and linoleate as assessed by plasma malondialdehyde and F2-isoprostanes Am. J. Clin. Nutr. 72 2000 714 722
144. A. Garrido, F. Garrido, R. Guerra, and A. Valenzuela Ingestion of high doses of fish oil increases the susceptibility of cellular membranes to the induction of oxidative stress Lipids 24 1989 833 835
145. D. Harats, Y. Dabach, and G. Hollander Fish oil ingestion in smokers enhances peroxidation of plasma lipoproteins Atheroschlerosis 90 1991 127 139
146. M. Meydani, F. Natiello, and B. Goldin Effect of long-term fish oil supplementation on vitamin E status and lipid peroxidation in women J. Nutr. 121 1991 484 491
147. T.A. Mori, D.W. Dunstan, V. Burke, K.D. Croft, J.H. Rivera, and L.J. Beilin Effect of dietary fish and exercise training on urinary F2-isoprostane excretion in non-insulin-dependent diabetic patients Metabolism 48 1999 1402 1408
148. R.C. Wander, S.H. Du, S.O. Ketchum, and K.E. Rowe Alpha-tocopherol influences in vivo indices of lipid peroxidation in postmenopausal women given fish oil J. Nutr. 126 1996 643 652
149. L.G. Wood, D.A. Fitzgerald, and M.L. Garg Hypothesis: vitamin E complements polyunsaturated fatty acids in essential fatty acid deficiency in cystic fibrosis J. Am. Coll. Nutr. 22 2003 253 257